Elective ambulatory labor induction with misoprostol in low risk obstetrical patients: a controlled clinical trial

Authors

  • Orlando Borré Arrieta
  • Benjamín Rodríguez Yances
  • William Angarita Peñaranda
  • Antonio Chamat Barrios
  • Édgar Gómez Rhenals

DOI:

https://doi.org/10.18597/rcog.597

Keywords:

misoprostol, induction, ambulatory, elective

Abstract

Introduction: the elective induction of labor in low risk patients allows the obstetrician to potentially decrease adverse effects caused by maternal anxiety at the end of the pregnancy. The objective of this investigation is to determine the security and effectiveness of the misoprostol in the ambulatory elective induction of labor in low risk patients with term pregnancies attending the Clinical Maternity Rafael Calvo in Cartagena, Colombia.

Methodology: a randomized controlled trial with placebo was done in low risk term pregnant patients that consulted to the Maternity from May 1st 2002 to the end of March of 2004. Patients were distributed in 3 groups: in patient misoprostol, ambulatory misoprostol, and placebo. Data was analyzed using two-way ANOVA and Chi square.

Results: 20 patients were assigned to the in-patient group, 20 to the out-patient group, and 6 patients in the placebo group. There was a shorter time interval to initiate labor in the group of ambulatory misoprostol. Adverse effects were no different in the three groups.

Conclusion: misoprostol used in ambulatory elective induction of labor is safe and effective.

Author Biographies

Orlando Borré Arrieta

Ginecólogo Obstetra, Profesor Titular, Departamento de Ginecología y Obstetricia, Universidad de Cartagena, Bolívar, Colombia.

Benjamín Rodríguez Yances

 Ginecólogo Obstetra, Profesor asociado.

William Angarita Peñaranda

Ginecólogo Obstetra, Candidato a Magister.

Antonio Chamat Barrios

Residente III, Ginecología y Obstetricia.

Édgar Gómez Rhenals

Residente III, Ginecología y Obstetricia.

References

Borré O, Rodríguez B, Mendivil C, Angarita W, Borré J. Inducción del trabajo de parto con Misoprostol vs. Oxitocina. Rev Colomb Obstet Ginecol 2000;51:7-11.

Magann EF, Perry KG Jr, Dockery JR Jr, Bass JD, Chauhan SP, Morrison JC. Cervical ripening before medical induction of labor: a comparison of prostaglandin E2, estradiol and oxytocin. Am J Obstet Gynecol 1995;172:1702-8.

Kramer RL, Gilson GJ, Morrison DS, Martin D, Gonzales JL, Qualls CR. A randomized trial of misoprostol and oxytocin for induction of labor: safety and efficacy. Obstet Gynecol 1997;89:387-91.

Sanchez-Ramos L, Kaunitz A, Wears R, Delke I, Gaudier F. Misoprostol for cervical ripening and labor induction: a meta-analysis. Obstet Gynecol 1997;89:633-42.

Wing DA, Jones MM, Rahall A, Goodwin TM, Paul RH. A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction. Am J Obstet Gynecol 1995;172:1804-10.

Fletcher H, Mitchell S, Simeon D, Frederick J, Simeon D, Brown D. Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents. Obstet Gynecol 1994;83:244-7.

Lemancewicz A, Urban R, Skotnicki M, Karpiuk A, Urban J. Uterine and fetal Doppler flow changes after misoprostol and oxytocin therapy for induction of labor in post-term pregnancies. Int J Gynaecol Obstet 1999;67:139-45.

Thomas N, Longo S, Rumney P, Nageotte M, Asrat T. Intravaginal misoprostol in prelabor rupture of membrane. Am J Obstet Gynecol 2000;182:S136.

Edwards M, Adair D, Vice J, Weeks J, Poole C, Lewis D. Outpatient postdate pregnancy management with misoprostol. A randomized, double-blind trial. Am J Obstet Gynecol 1998;178:S94.

Ascher-Wash C, Burke B, Baxi L. Outpatient management of prolonged pregnancy with misoprostol; a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 2000;182:S20.

Sánchez-Ramos L, Kaunitz A. Misoprostol para la maduracion cervicouterina e induccion del trabajo de parto: revision sistemática de las publicaciones. En: Pitkin R, Scott J. Clinicas Obstétricas y Ginecológicas. Pensilvania: Mc Graw Hill interamericana; 2000. p. 489-500.

Keirse M. Prostaglandins in preinduction cervical ripening: meta-analysis of worldwide clinical experience. J Reprod Med 1993;38(Suppl 1):89-100.

Gilson GJ, Izquierdo LA, Chatterjee MS, Curet LB, Qualls CR. Prevention of cesarean section. Does intracervical dinoprostone work? West J Med 1993;159:149-52.

Stitely ML, Browning J, Fowler M, Gendron RT, Gherman RB. Outpatient cervical ripening with intravaginal misoprostol. Obstet Gynecol 2001;97:325-6.

How to Cite

1.
Borré Arrieta O, Rodríguez Yances B, Angarita Peñaranda W, Chamat Barrios A, Gómez Rhenals Édgar. Elective ambulatory labor induction with misoprostol in low risk obstetrical patients: a controlled clinical trial. Rev. colomb. obstet. ginecol. [Internet]. 2004 Jun. 30 [cited 2024 May 17];55(2):107-13. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/597

Downloads

Download data is not yet available.

Published

2004-06-30

Issue

Section

Original Research
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo

Some similar items: